| Computation of Basic and Diluted Earnings Per Share, Including Antidilutive Securities Excluded from Computation of Earnings Per Share |
Basic and diluted earnings per share for the three and six months ended June 30, 2021 and 2020, respectively consisted of the following (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Numerator (Basic and Diluted): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
$ |
31,532 |
|
|
$ |
106 |
|
|
$ |
46,544 |
|
|
$ |
13,176 |
|
Change in value for stock settled consideration |
|
|
(42 |
) |
|
|
— |
|
|
|
10 |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
$ |
31,490 |
|
|
$ |
106 |
|
|
$ |
46,554 |
|
|
$ |
13,176 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares issued and outstanding |
|
|
39,549 |
|
|
|
39,306 |
|
|
|
39,491 |
|
|
|
39,261 |
|
Deduct: Unvested RSAs (1)
|
|
|
(14 |
) |
|
|
(19 |
) |
|
|
(16 |
) |
|
|
(18 |
) |
Add: Fully vested DSUs (2)
|
|
|
342 |
|
|
|
342 |
|
|
|
342 |
|
|
|
342 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
39,877 |
|
|
|
39,629 |
|
|
|
39,817 |
|
|
|
39,585 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share |
|
$ |
0.79 |
|
|
$ |
— |
|
|
$ |
1.17 |
|
|
$ |
0.33 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding from above |
|
|
39,877 |
|
|
|
39,629 |
|
|
|
39,817 |
|
|
|
39,585 |
|
Add: Dilutive effect of RSUs, RSAs & ESPP |
|
|
149 |
|
|
|
44 |
|
|
|
182 |
|
|
|
77 |
|
Add: Contingently issuable shares
|
|
|
113 |
|
|
|
— |
|
|
|
113 |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
40,139 |
|
|
|
39,673 |
|
|
|
40,112 |
|
|
|
39,662 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share |
|
$ |
0.78 |
|
|
$ |
— |
|
|
$ |
1.16 |
|
|
$ |
0.33 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antidilutive shares excluded from diluted earnings per common share (4)
|
|
|
48 |
|
|
|
738 |
|
|
|
275 |
|
|
|
636 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
RSAs were issued and outstanding to the non-employee directors and have a one-year vesting term subject to service requirements. See Note 10 – “Stock-Based Compensation Plans” for additional information. |
(2) |
Shares are included in weighted average common shares outstanding as the shares are fully vested but have not yet been delivered. See Note 10 – “Stock-Based Compensation Plans” for additional information. |
(3) |
Relates to contingently issuable stock settled consideration. |
(4) |
Primarily pertaining to RSU grants to the Company’s employees and independent contractors.
|
|